Distinguishing characteristics of difficult-to-control asthma in inner-city children and adolescents

J Allergy Clin Immunol. 2016 Oct;138(4):1030-1041. doi: 10.1016/j.jaci.2016.06.059.

Abstract

Background: Treatment levels required to control asthma vary greatly across a population with asthma. The factors that contribute to variability in treatment requirements of inner-city children have not been fully elucidated.

Objective: We sought to identify the clinical characteristics that distinguish difficult-to-control asthma from easy-to-control asthma.

Methods: Asthmatic children aged 6 to 17 years underwent baseline assessment and bimonthly guideline-based management visits over 1 year. Difficult-to-control and easy-to-control asthma were defined as daily therapy with 500 μg of fluticasone or greater with or without a long-acting β-agonist versus 100 μg or less assigned on at least 4 visits. Forty-four baseline variables were used to compare the 2 groups by using univariate analyses and to identify the most relevant features of difficult-to-control asthma by using a variable selection algorithm. Nonlinear seasonal variation in longitudinal measures (symptoms, pulmonary physiology, and exacerbations) was examined by using generalized additive mixed-effects models.

Results: Among 619 recruited participants, 40.9% had difficult-to-control asthma, 37.5% had easy-to-control asthma, and 21.6% fell into neither group. At baseline, FEV1 bronchodilator responsiveness was the most important characteristic distinguishing difficult-to-control asthma from easy-to-control asthma. Markers of rhinitis severity and atopy were among the other major discriminating features. Over time, difficult-to-control asthma was characterized by high exacerbation rates, particularly in spring and fall; greater daytime and nighttime symptoms, especially in fall and winter; and compromised pulmonary physiology despite ongoing high-dose controller therapy.

Conclusions: Despite good adherence, difficult-to-control asthma showed little improvement in symptoms, exacerbations, or pulmonary physiology over the year. In addition to pulmonary physiology measures, rhinitis severity and atopy were associated with high-dose asthma controller therapy requirement.

Keywords: Child; IgE; allergen sensitization; asthma; asthma exacerbations; asthma morbidity; asthma phenotype; asthma severity; inner-city asthma; pulmonary function; rhinitis.

Publication types

  • Clinical Trial
  • Research Support, N.I.H., Extramural

MeSH terms

  • Adolescent
  • Age of Onset
  • Anti-Asthmatic Agents / therapeutic use*
  • Asthma / complications
  • Asthma / drug therapy*
  • Asthma / physiopathology*
  • Baltimore
  • Child
  • Female
  • Humans
  • Longitudinal Studies
  • Male
  • Medical History Taking
  • Poverty
  • Prospective Studies
  • Rhinitis / complications
  • Rhinitis / drug therapy
  • Rhinitis / physiopathology
  • Severity of Illness Index
  • Urban Population*

Substances

  • Anti-Asthmatic Agents